Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review.

Bagkaki, Alena; Tsoutsinos, Alexandros; Hatzidaki, Eleftheria; Tzatzarakis, Manolis; Parthenakis, Fragiskos; Germanakis, Ioannis

Bagkaki, Alena; Tsoutsinos, Alexandros; Hatzidaki, Eleftheria; Tzatzarakis, Manolis; Parthenakis, Fragiskos; Germanakis, Ioannis.

Afiliación

Bagkaki A; Pediatric Cardiology Unit, Department of Pediatrics, School of Medicine, University Hospital Heraklion, University of Crete, Heraklion, Greece.
Tsoutsinos A; Department of Pediatric Cardiology and Adult Congenital Heart Disease, Onassis Cardiac Surgery Center, Athens, Greece.
Hatzidaki E; Department of Neonatology, School of Medicine, University Hospital Heraklion, University of Crete, Heraklion, Greece.
Tzatzarakis M; Laboratory of Toxicology, School of Medicine, University of Crete, Heraklion, Greece.
Parthenakis F; Department of Cardiology, School of Medicine, University Hospital Heraklion, University of Crete, Heraklion, Greece.
Germanakis I; Pediatric Cardiology Unit, Department of Pediatrics, School of Medicine, University Hospital Heraklion, University of Crete, Heraklion, Greece.

Front Pediatr ; 9: 674041, 2021.

Article en En | MEDLINE | ID: mdl-34504812

Palabras clave

LQT syndrome; LQT3; QT prolongation; SCN5A mutation; case report; child; mexiletine; neonate

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Pediatr Año: 2021 Tipo del documento: Article País de afiliación: Grecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google